Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2016 1
2018 2
2019 3
2020 3
2021 4
2022 5
2023 7
2024 1
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Kowal-Bielecka O, Riccardi A, Distler O; EUSTAR collaborators. Hoffmann-Vold AM, et al. Ann Rheum Dis. 2021 Feb;80(2):219-227. doi: 10.1136/annrheumdis-2020-217455. Epub 2020 Sep 28. Ann Rheum Dis. 2021. PMID: 32988845 Free PMC article.
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y; EUSTAR collaborators. Lescoat A, et al. JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729. JAMA Dermatol. 2023. PMID: 37378994 Free PMC article.
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib.
Lopalco G, Celletti E, Morrone M, Atzeni F, Limonta M, Rossini M, Carletto A, Cauli A, Cazzato M, Chimenti MS, Conti F, Rotondo C, Leccese P, Foti R, Gentileschi S, Gremese E, Selmi CF, Bazzani C, Guggino G, Guiducci S, Di Penta M, Lo Gullo A, Luchetti Gentiloni MM, Bugatti S, Ramonda R, Sebastiani M, Semeraro A, Santo L, Caporali RF, Iannone F. Lopalco G, et al. Among authors: selmi cf. Rheumatology (Oxford). 2025 Aug 4:keaf411. doi: 10.1093/rheumatology/keaf411. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40758456
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.
Wyss A, Jordan S, Graf N, Carreira PE, Distler J, Cerinic MM, Siegert E, Henes J, Zanatta E, Riccieri V, Truchetet ME, Oksel F, Li M, Kucharz EJ, Eyerich K, Del Galdo F, Vonk MC, Vold AH, Gabrielli A, Distler O; EUSTAR collaborators. Wyss A, et al. Arthritis Res Ther. 2024 Oct 31;26(1):187. doi: 10.1186/s13075-024-03418-2. Arthritis Res Ther. 2024. PMID: 39482761 Free PMC article.
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database.
Mongin D, Matucci-Cerinic M, Walker UA, Distler O, Becvar R, Siegert E, Ananyeva LP, Smith V, Alegre-Sancho JJ, Yavuz S, Limonta M, Riemekasten G, Rezus E, Vonk M, Truchetet ME, Del Galdo F, Courvoisier DS, Iudici M; EUSTAR Collaborators. Mongin D, et al. Arthritis Care Res (Hoboken). 2025 May;77(5):649-657. doi: 10.1002/acr.25469. Epub 2025 Jan 14. Arthritis Care Res (Hoboken). 2025. PMID: 39542851 Free article. Clinical Trial.
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.
Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, Riemekasten G, Distler JHW, Rosato E, Del Galdo F, Mendoza FA, Furst DE, de la Puente C, Hoffmann-Vold AM, Gabrielli A, Distler O, Bloch-Queyrat C, Allanore Y; EUSTAR collaborators. Elhai M, et al. Lancet Rheumatol. 2022 Nov;4(11):e785-e794. doi: 10.1016/S2665-9913(22)00217-X. Lancet Rheumatol. 2022. PMID: 38265945
The impact of the COVID-19 pandemic on the global assessments of rheumatology clinimetrics: Data from a mobile application. A comment on article by Nagy E, et al.: "The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned".
Tomšič N, Tomšič M, Rotar Ž, Hočevar A, Savevski V, Selmi CF. Tomšič N, et al. Among authors: selmi cf. Autoimmun Rev. 2022 Mar;21(3):103020. doi: 10.1016/j.autrev.2021.103020. Epub 2021 Dec 15. Autoimmun Rev. 2022. PMID: 34920106 Free PMC article. No abstract available.
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study.
Sobanski V, de Vries-Bouwstra J, Hoffmann-Vold AM, Huscher D, Alves M, Matucci-Cerinic M, Riemekasten G, Li M, Czirják L, Kowal-Bielecka O, Allanore Y, Schoof N, Distler O; EUSTAR Collaborators. Sobanski V, et al. Rheumatology (Oxford). 2025 Oct 1;64(10):5344-5353. doi: 10.1093/rheumatology/keaf264. Rheumatology (Oxford). 2025. PMID: 40457805 Free PMC article.
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort.
Bellando-Randone S, Wilhalme H, Bruni C, Czirjak L, Distler O, Allanore Y, Cuomo G, Denton C, Del Galdo F, Gheorghiu AM, Riccieri V, Walker U, Truchetet ME, Vonk MC, Foeldvari I, Matucci-Cerinic M, Furst DE; and the EUSTAR collaborators. Bellando-Randone S, et al. Arthritis Res Ther. 2025 Mar 27;27(1):66. doi: 10.1186/s13075-025-03476-0. Arthritis Res Ther. 2025. PMID: 40148996 Free PMC article.
28 results